How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model?
dc.authorid | 0000-0002-7817-855X | |
dc.contributor.author | Ebru, Afşar | |
dc.contributor.author | Kantar Gül, Deniz | |
dc.date.accessioned | 2025-01-28T12:07:06Z | |
dc.date.available | 2025-01-28T12:07:06Z | |
dc.date.issued | 2025 | en_US |
dc.department | Kapadokya Üniversitesi, Diş Hekimliği Fakültesi, Diş Hekimliği Bölümü | |
dc.description.abstract | Background: The present study aimed to evaluate the impact of Cyclo-Z, a combination of Cyclo (His-Pro) plus zinc, on hepatic sphingolipid (SL) metabolism and antioxidant properties in a rat model of Alzheimer's disease (AD). Methods: Alzheimer's disease rat model created via intracerebroventricular (i.c.v.) amyloid beta-42 oligomer (A?O) injection into the lateral ventricles. Cyclo-Z administration was performed with daily gavage for 3 weeks after the A?O injection. Ceramide, ceramide kinase (CERK), sphingosine 1 phosphate (S1P), glutathione (GSH), total oxidant capacity (TOS), 4-hydroxynonenal (HNE) and caspase-3 levels were measured with Elisa kit in liver tissue. Results: S1P, CERK and GSH levels increased and ceramide, TOS, 4 HNE, and caspase-3 levels decreased in the liver tissues of AD group. Cyclo-Z treatment decreased S1P, CERK, ceramide and caspase-3 levels but increased TOS and 4-HNE levels in the liver tissues of AD group. Conclusion: These results showed that SL metabolism was modulated to generate an anti-apoptotic defense system in liver tissue of AD rats. | |
dc.description.sponsorship | Kültür Üniversitesi | |
dc.identifier.uri | https://pubmed.ncbi.nlm.nih.gov/39809015/ | |
dc.identifier.uri | https://doi.org/10.1016/j.jtemb.2025.127589 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12695/3160 | |
dc.institutionauthor | Afşar, Ebru | |
dc.language.iso | en | |
dc.publisher | ELSEVIER | |
dc.relation.ispartof | Journal of Trace Elements in Medicine and Biology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Alzheimer's disease | |
dc.subject | Ceramide | |
dc.subject | Sphingosine 1 phosphate | |
dc.subject | Zinc | |
dc.title | How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model? | |
dc.type | Article |